Molecular pharmacology of second-generation antihistamines.

Keyphrases

• Molecular Pharmacology 100%
• Histamine 100%
• H1-antihistamines 100%
• H1 Receptor 75%
• Antihistamines 75%
• Clinical Trials 25%
• Asthma 25%
• Allergy 25%
• Central Nervous System 25%
• Rhinitis 25%
• Blood-brain Barrier 25%
• Clinical Application 25%
• Cell Recruitment 25%
• Allergic Rhinitis 25%
• Enhanced Efficacy 25%
• Allergic Reaction 25%
• Allergic Mediators 25%
• Cellular Activation 25%
• Non-specific Binding 25%
• Mediator Release 25%
• Wheals 25%
• Leukotriene Receptor Antagonist 25%
• Flare Response 25%
• Anti-allergic 25%
• Drowsiness 25%
• Receptor Specificity 25%
• Allergic Urticaria 25%
• H1 Antagonists 25%
• Central Nervous System Penetration 25%
• Adverse Effect Profile 25%
• Psychomotor Impairment 25%
• System Interference 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Histamine 100%
• Antihistaminic Agent 100%
• Molecular Pharmacology 100%
• Histamine H1 Receptor 75%
• Clinical Trial 25%
• Adverse Event 25%
• Side Effect 25%
• Receptor 25%
• Blood-Brain Barrier 25%
• Asthma 25%
• Allergic Rhinitis 25%
• Allergic Reaction 25%
• Rhinitis 25%
• Urticaria 25%
• Leukotriene Receptor Blocking Agent 25%
• Histamine H1 Receptor Antagonist 25%
• Antiallergic 25%
• Allergic Urticaria 25%
• Psychomotor Disorder 25%

Immunology and Microbiology

• Histamine 100%
• Central Nervous System 50%
• Mediator 25%
• Asthma 25%
• Rhinitis 25%
• Allergic Rhinitis 25%
• Hypersensitive Response 25%
• Mediator Release 25%
• Blood Brain Barrier 25%
• Leukotriene Antagonist 25%
• Histamine H1 Receptor Antagonist 25%